The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
Drs. Pam Taub, Erin Michos, and Jennifer Green discuss the burden of CKD as a major driver of cardiovascular and renal morbidity and mortality in women and review practical considerations for the application of SGLT2 inhibitors to improve renal outcomes in women with or at-risk for CKD. Recorded at the 2024 Women's Health & Wellness Masterclass meeting on April 19, 2024.
Login to view comments.
Click here to Login
